DZ3285A1 - Monohydrate cis-lithium-4-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate - Google Patents

Monohydrate cis-lithium-4-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate

Info

Publication number: DZ3285A1
Authority: DZ; Algeria
Prior art keywords: cyclohexanecarboxylate; cyclopentyloxy; monohydrate; cis; cyano
Prior art date: 2000-01-26

Application number

DZ013285A

Other languages

English (en)

Inventor

Kevin Scott Webb

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-26

Filing date

2001-01-18

Publication date

2001-08-02

2001-01-18 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-08-02 Application granted granted Critical

2001-08-02 Publication of DZ3285A1 publication Critical patent/DZ3285A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DZ013285A 2000-01-26 2001-01-18 Monohydrate cis-lithium-4-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate DZ3285A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17812900P	2000-01-26	2000-01-26
PCT/US2001/001487 WO2001055094A1 (fr)	2000-01-26	2001-01-18	Cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate monohydrate

Publications (1)

Publication Number	Publication Date
DZ3285A1 true DZ3285A1 (fr)	2001-08-02

Family

ID=22651319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ013285A DZ3285A1 (fr)	2000-01-26	2001-01-18	Monohydrate cis-lithium-4-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate

Country Status (36)

Country	Link
US (1)	US6699903B2 (fr)
EP (1)	EP1250313B1 (fr)
JP (1)	JP2003520842A (fr)
KR (1)	KR20020073183A (fr)
CN (1)	CN1157371C (fr)
AP (1)	AP1432A (fr)
AR (1)	AR027273A1 (fr)
AT (1)	ATE344235T1 (fr)
AU (1)	AU3282201A (fr)
BG (1)	BG106959A (fr)
BR (1)	BR0107709A (fr)
CA (1)	CA2397758A1 (fr)
CO (1)	CO5300517A1 (fr)
CY (1)	CY1108515T1 (fr)
CZ (1)	CZ20022590A3 (fr)
DE (1)	DE60124221T2 (fr)
DK (1)	DK1250313T3 (fr)
DZ (1)	DZ3285A1 (fr)
EA (1)	EA200200791A1 (fr)
EG (1)	EG24065A (fr)
ES (1)	ES2273804T3 (fr)
HK (1)	HK1051030A1 (fr)
HU (1)	HUP0204150A3 (fr)
IL (1)	IL150400A0 (fr)
MA (1)	MA25652A1 (fr)
MX (1)	MXPA02007300A (fr)
MY (1)	MY122802A (fr)
NO (1)	NO20023378L (fr)
NZ (1)	NZ519799A (fr)
OA (1)	OA12159A (fr)
PE (1)	PE20011040A1 (fr)
PL (1)	PL356832A1 (fr)
PT (1)	PT1250313E (fr)
SK (1)	SK10942002A3 (fr)
WO (1)	WO2001055094A1 (fr)
ZA (1)	ZA200205925B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0011802D0 (en) *	2000-05-16	2000-07-05	Smithkline Beecham	Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU225869B1 (en) *	1992-04-02	2007-11-28	Smithkline Beecham Corp	Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
UA67753C2 (uk) *	1997-10-10	2004-07-15	Смітклайн Бічам Корпорейшн	Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

2001
- 2001-01-18 EP EP01904886A patent/EP1250313B1/fr not_active Expired - Lifetime
- 2001-01-18 SK SK1094-2002A patent/SK10942002A3/sk unknown
- 2001-01-18 WO PCT/US2001/001487 patent/WO2001055094A1/fr not_active Ceased
- 2001-01-18 KR KR1020027009545A patent/KR20020073183A/ko not_active Ceased
- 2001-01-18 AP APAP/P/2002/002566A patent/AP1432A/en active
- 2001-01-18 ES ES01904886T patent/ES2273804T3/es not_active Expired - Lifetime
- 2001-01-18 MX MXPA02007300A patent/MXPA02007300A/es active IP Right Grant
- 2001-01-18 DK DK01904886T patent/DK1250313T3/da active
- 2001-01-18 HK HK03101828.3A patent/HK1051030A1/zh unknown
- 2001-01-18 IL IL15040001A patent/IL150400A0/xx unknown
- 2001-01-18 AT AT01904886T patent/ATE344235T1/de not_active IP Right Cessation
- 2001-01-18 CA CA002397758A patent/CA2397758A1/fr not_active Abandoned
- 2001-01-18 PT PT01904886T patent/PT1250313E/pt unknown
- 2001-01-18 PL PL01356832A patent/PL356832A1/xx not_active IP Right Cessation
- 2001-01-18 EA EA200200791A patent/EA200200791A1/ru unknown
- 2001-01-18 BR BR0107709-0A patent/BR0107709A/pt not_active IP Right Cessation
- 2001-01-18 US US10/181,865 patent/US6699903B2/en not_active Expired - Fee Related
- 2001-01-18 HU HU0204150A patent/HUP0204150A3/hu unknown
- 2001-01-18 JP JP2001555036A patent/JP2003520842A/ja not_active Withdrawn
- 2001-01-18 DE DE60124221T patent/DE60124221T2/de not_active Expired - Lifetime
- 2001-01-18 OA OA1200200211A patent/OA12159A/en unknown
- 2001-01-18 DZ DZ013285A patent/DZ3285A1/fr active
- 2001-01-18 AU AU32822/01A patent/AU3282201A/en not_active Abandoned
- 2001-01-18 CN CNB018040160A patent/CN1157371C/zh not_active Expired - Fee Related
- 2001-01-18 CZ CZ20022590A patent/CZ20022590A3/cs unknown
- 2001-01-18 NZ NZ519799A patent/NZ519799A/en unknown
- 2001-01-23 MY MYPI20010322A patent/MY122802A/en unknown
- 2001-01-24 EG EG20010070A patent/EG24065A/xx active
- 2001-01-24 AR ARP010100298A patent/AR027273A1/es unknown
- 2001-01-25 PE PE2001000081A patent/PE20011040A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005892A patent/CO5300517A1/es not_active Application Discontinuation
2002
- 2002-07-12 NO NO20023378A patent/NO20023378L/no not_active Application Discontinuation
- 2002-07-24 ZA ZA200205925A patent/ZA200205925B/en unknown
- 2002-07-24 MA MA26744A patent/MA25652A1/fr unknown
- 2002-07-26 BG BG106959A patent/BG106959A/xx unknown
2007
- 2007-01-10 CY CY20071100034T patent/CY1108515T1/el unknown

Also Published As

Publication number	Publication date
PE20011040A1 (es)	2001-10-31
CN1157371C (zh)	2004-07-14
PL356832A1 (en)	2004-07-12
BR0107709A (pt)	2002-11-19
EP1250313A1 (fr)	2002-10-23
IL150400A0 (en)	2002-12-01
DK1250313T3 (da)	2007-02-12
MY122802A (en)	2006-05-31
EP1250313B1 (fr)	2006-11-02
MXPA02007300A (es)	2002-11-29
NO20023378D0 (no)	2002-07-12
BG106959A (en)	2003-05-30
CO5300517A1 (es)	2003-07-31
ES2273804T3 (es)	2007-05-16
AP1432A (en)	2005-06-20
DE60124221D1 (de)	2006-12-14
EG24065A (en)	2008-05-08
HUP0204150A3 (en)	2003-05-28
CN1395556A (zh)	2003-02-05
WO2001055094A1 (fr)	2001-08-02
NZ519799A (en)	2004-04-30
CY1108515T1 (el)	2014-04-09
US20030032670A1 (en)	2003-02-13
AP2002002566A0 (en)	2002-06-30
MA25652A1 (fr)	2002-12-31
NO20023378L (no)	2002-07-12
HUP0204150A2 (hu)	2003-04-28
JP2003520842A (ja)	2003-07-08
EP1250313A4 (fr)	2005-09-21
SK10942002A3 (sk)	2002-11-06
PT1250313E (pt)	2007-01-31
HK1051030A1 (zh)	2003-07-18
ATE344235T1 (de)	2006-11-15
DE60124221T2 (de)	2007-09-13
AU3282201A (en)	2001-08-07
US6699903B2 (en)	2004-03-02
AR027273A1 (es)	2003-03-19
CZ20022590A3 (cs)	2003-01-15
EA200200791A1 (ru)	2002-12-26
ZA200205925B (en)	2003-11-21
KR20020073183A (ko)	2002-09-19
CA2397758A1 (fr)	2001-08-02
OA12159A (en)	2006-05-08

Publication	Publication Date	Title
DZ3409A1 (fr)	2002-02-21	Association therapeuthique
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
DK1199054T3 (da)	2004-09-27	Væskefrakturhånddel
IS7291A (is)	2004-06-01	Merkt kirni
EP1374310A4 (fr)	2008-02-20	Nanofabrication
LU91584I2 (fr)	2009-09-10	Ustekinumab (Stelara)
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE50103020D1 (de)	2004-09-02	Positioniereinheit
ATE288437T1 (de)	2005-02-15	Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DE50114386D1 (de)	2008-11-20	Ng
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
DE50007505D1 (de)	2004-09-23	Positioniervorrichtung
DE50100088D1 (de)	2003-02-27	Irisblende
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE60108161D1 (de)	2005-02-03	Halo-krone
DE10197149T1 (de)	2003-11-20	Anti-Zusetz-Behandlungen
IS6610A (is)	2002-11-11	Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns
DE10193450D2 (de)	2003-10-02	Gehörschutzstöpsel
FI20010894A0 (fi)	2001-04-27	Kaksiosainen laite
MA25652A1 (fr)	2002-12-31	Monohydrate de cis-lithium-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
DE60233352D1 (de)	2009-09-24	Modulus-zwei-vorskaliererschaltung
ATA7642000A (de)	2000-11-15	Kopfband
ATE348799T1 (de)	2007-01-15	Substituierte cyclohexanderivate